Desuden bør patienter advares om risikoen for hypoglykæmi, når Velmetia anvendes sammen med andre sulfonylurinstoffer.
In addition, patients should be alerted to the risk of hypoglycaemia when Velmetia is used in combination with other sulfonylurea agents.